A Single-centre Study to Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Inhaled Formulation of AVONEX (Interferon Beta-1a) in Healthy Volunteers

Trial Profile

A Single-centre Study to Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Inhaled Formulation of AVONEX (Interferon Beta-1a) in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Interferon beta-1a (Primary) ; Interferon beta-1a
  • Indications Multiple sclerosis; Ulcerative colitis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Trio Medicines
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top